User profiles for R. Bjerke

Rune Bjerke

Associate professor at Kristiania University College
Verified email at kristiania.no
Cited by 849

Advances in precision oncology: targeted thorium-227 conjugates as a new modality in targeted alpha therapy

…, K Wickstroem, S Hammer, RM Bjerke… - Cancer Biotherapy & …, 2020 - liebertpub.com
Targeted α therapy (TAT) offers the potential for the targeted delivery of potent α-particle-emitting
radionuclides that emit high linear energy transfer radiation. This leads to a densely …

Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met

…, AJ Kales, R Bendiksen, B Indrevoll, RM Bjerke… - Nature medicine, 2015 - nature.com
Colon cancer prevention currently relies on colonoscopy using white light to detect and remove
polyps, but small and flat polyps are difficult to detect and frequently missed when using …

[BOOK][B] Branding governance: A participatory approach to the brand building process

N Ind, R Bjerke - 2007 - books.google.com
Branding Governance challenges traditional thinking on brands. Bestselling author Nicholas
Ind and cross-cultural communications expert Rune Bjerke expose the flaws in a marketing-…

Prevention of endotracheal tube-induced coughing during emergence from general anesthesia

RM Gonzalez, RJ Bjerke, T Drobycki… - Anesthesia & …, 1994 - journals.lww.com
Methods With institutional approval and written informed consent, 75 consecutive fasting
patients for general anesthesia for elective general, orthopedic, urologic, plastic, or vascular …

Preclinical efficacy of a PSMA-targeted thorium-227 conjugate (PSMA-TTC), a targeted alpha therapy for prostate cancer

…, P Lejeune, H Hennekes, J Karlsson, RM Bjerke… - Clinical Cancer …, 2020 - AACR
… Karlsson, RM Bjerke, and OB Ryan are employees/paid consultants for Bayer AS. AS
Cuthbertson is an employee/paid consultant for and holds ownership interest (including patents) in …

Mesothelin-targeted thorium-227 conjugate (MSLN-TTC): preclinical evaluation of a new targeted alpha therapy for mesothelin-positive cancers

…, S Uran, H Hennekes, J Karlsson, RM Bjerke… - Clinical Cancer …, 2019 - AACR
… All analyses of the in vivo efficacy of BAY 2287411 were performed using the statistical
programming language R (version 3.4.3). Validity of the model assumptions was checked for …

[HTML][HTML] The concept of participatory market orientation: An organisation-wide approach to enhancing brand equity

N Ind, R Bjerke - Journal of Brand Management, 2007 - Springer
While much marketing literature sees delivering customer experience as the role of the
marketer, we argue that this is an organisation-wide responsibility. The organisation-wide …

Eliminating arterial injury during central venous catheterization using manometry

…, TM Oravitz, JW Ibinson, RJ Bjerke - Anesthesia & …, 2009 - journals.lww.com
BACKGROUND: Unintended arterial puncture occurs in 2%-4.5% of central venous
catheterizations, resulting in arterial injury in 0.1%-0.5% of patients. Routine performance of …

In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia

…, AO Shea, K Sponheim, J Karlsson, RM Bjerke… - Molecular cancer …, 2016 - AACR
The clinical efficacy of the first approved alpha pharmaceutical, Xofigo (radium-223
dichloride, 223 RaCl 2 ), has stimulated significant interest in the development of new alpha-particle …

How well do advertising images of health and beauty travel across cultures? A self‐concept perspective

R Bjerke, R Polegato - Psychology & Marketing, 2006 - Wiley Online Library
This study is a cross‐cultural examination of the ideal self‐image of women in terms of health
and beauty. The match‐up between two advertising beauty types (possible advertising …